Skip to main content
. 2022 May 16;9:857879. doi: 10.3389/fnut.2022.857879

FIGURE 3.

FIGURE 3

Effects of POD and RES on glucolipid metabolism and fatty liver. (A) Food intake. (B) Insulin tolerance test (ITT) and the area under the curve (AUC). (C) Homeostasis model assessment -insulin resistance (HOMR-IR, HOMA-IR = Glucose [mmol/L] × Insulin [mU/L] ÷ 22.5). (D) Serum insulin level. (E) Fasting blood glucose level (FBG) and AUC of FBG. (F) Serum HbA1c level. (G–J) Hepatic periodic acid-schiff (PAS) (200×), MASSON (200×), Oil red O (200×), and HE stainings (200×), respectively. (K–M) Total cholesterol (TC), triglycerides (TG), and free fatty acid (FFA) in liver, respectively. (N–Q) Serum levels of TC, TG, FFA, and low-density lipoprotein-cholesterol (LDL-C), respectively. Data are presented as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001. # p < 0.05, ## p < 0.01, ### p < 0.001, compared to model group. & p < 0.05, compared to POD group. NS, p > 0.05.